In 2025, the Clinical Data Management field will undergo significant transformation, driven by advancements in biometric data technology and the tightening of regulatory standards. With the rise of new data management solutions, precision medicine, and deeper integration of biometric analysis into clinical practices, there will be a clear shift in how healthcare is delivered.

Key funding opportunities are emerging in wearable sensors, AI-powered diagnostics, and secure data management systems. These developments are set to change not only how healthcare is managed but also the roles of professionals handling and interpreting this vital data.

In this guide, we examine the funding trends for 2025 and the key opportunities and challenges shaping the future of biometric and data management jobs.

Factors Influencing Funding in 2025

As grants and funding continue to play a significant role in advancing Biometrics and Clinical Data Management, understanding the external factors that shape these decisions is essential. In 2025, developments in privacy laws, regulatory scrutiny, and industry shifts will likely influence where and how funding is allocated. Here’s a closer look at the factors to keep an eye on.

Increased Scrutiny Around Data Privacy

As biometric data protection remains a focal point, regulations like HIPAA will influence which projects attract funding. Efforts that prioritize secure handling of patient data in clinical trials and other sensitive settings are likely more appealing to funders, especially as data protection becomes a higher priority in both the public and private sectors.

State Privacy Laws

With more states introducing their own privacy regulations, such as the California Consumer Privacy Act (CCPA), these will likely affect how biometric data is collected, stored, and shared in clinical trials. As privacy requirements tighten, funding may lean toward initiatives that align with these evolving standards, especially for projects handling personal and health data.

DOJ Rulemaking on Data Transfers

New rules around the transfer of biometric data across borders could impact which projects qualify for funding. While it’s unclear exactly how these regulations will be enforced, organizations working with international data must ensure secure and compliant data handling to remain eligible for grants.

Innovation and Data-Driven Projects

Despite regulatory challenges, areas like wearable sensors, biometric data integration into EHRs, and digital biomarkers are expected to draw attention. Projects that use biometric analysis to advance Clinical Data Management and patient care may still find ample funding, particularly as demand for innovative healthcare solutions grows.

Overall, these trends point toward a focus on secure, innovative approaches to Biometrics and Clinical Data Management. While specific funding impacts are still to be fully understood, these focus areas might guide funding decisions and prioritize projects that meet evolving standards and showcase data security, innovation, and real-world applications in healthcare.

Key Areas of Investment in 2025

In 2025, U.S. federal funding is focused on advancing healthcare technologies, improving patient care, and strengthening national security. A significant portion of funding is dedicated to healthcare technology, including Clinical Data Management and the integration of biometric data. These investments aim to enhance patient outcomes and support the broader technological and public health needs of the country.

As Monica M. Bertagnolli, M.D., Director of the National Institutes of Health, stated, “My hope is to integrate basic research with public health and clinical care data, and, crucially, more rapidly disseminate evidence to guide patient and provider decisions, tracking progress for outcomes that matter to the people we serve.”

Agencies like the NIH and ONC are focusing on research and development in areas like AI-powered diagnostics, digital biomarkers, and better integration of biometric data into clinical trials and patient monitoring systems. The goal is to make healthcare more personalized, efficient, and secure.

Key funding areas to watch in 2025 include:

• Wearable Sensors & Remote Monitoring: Investment in devices that track vital signs in real-time, enabling remote patient monitoring and improved care.
• AI & Precision Medicine: Funding for AI-driven solutions that personalize diagnostics and treatments, ensuring better patient outcomes.
• Biometric Data & EHR Integration: Efforts to integrate biometric data with Electronic Health Records (EHRs), creating more complete patient profiles and enhancing decision-making.

While the full impact of these investments is still unfolding, these areas will drive growth in Clinical Data Management and Biometrics, providing plenty of opportunities for innovation and progress in 2025.

Types of Grants and Funding Available 

The role of funding in advancing biometric data research and Clinical Data Management (CDM) is key to research success in 2025. Federal and private sector contributions are steering innovation, shaping infrastructure, and enabling the secure integration of biometric data into clinical trials and broader healthcare systems. 

These investments address regulatory demands, refine biostatistical methods, and enhance data privacy and security protocols critical to the life sciences sector.

Governmental Funding in 2025

Federal funding is a key driver in advancing biometric data research in 2025, especially within healthcare technologies and real-time data integration. The U.S. Department of Health and Human Services (HHS) FY2025 budget of $130.7 billion in discretionary funding and $1.7 trillion in mandatory funding reflects the federal commitment to using data to address the nation’s healthcare challenges. 

Additionally, the FY2025 budget includes $20 billion in mandatory funding through the Public Health and Social Services Emergency Fund (PHSSEF) to help prepare for and respond to future pandemics and biological threats. This includes $2.69 billion for the NIH to expand research on vaccines, therapeutics, and diagnostics, as well as improving lab capacity and clinical trial infrastructure—critical areas for the continued use of biometric data in health crises.

Key Agencies and Programs in 2025

National Institutes of Health (NIH)

The NIH has requested $50.1 billion in 2025, focusing on expanding programs like the All of Us Research Program, which integrates biometric data to personalize healthcare. This initiative continues to advance precision medicine by using biometric data to create individualized treatment plans.

Advanced Research Projects Agency for Health (ARPA-H)

ARPA-H has requested $1.5 billion in 2025 to enhance clinical trial efficiency through real-time biometric data collection. ARPA-H also aims to improve privacy-enhancing technologies to comply with HIPAA and other data protection regulations, ensuring the secure management of biometric data.

National Institute of Standards and Technology (NIST)

NIST’s Biometric Standards and Testing Program continues to receive funding in 2025 to refine biometric standards and improve interoperability across sectors, facilitating the seamless use of biometric data in healthcare and clinical trials.

Intelligence Advanced Research Projects Activity (IARPA)

IARPA’s Odin Program is investing in advanced biometric technologies and data management techniques. This funding supports the real-time processing and analysis of large-scale biometric data, benefiting both healthcare and national security.

Centers for Disease Control and Prevention (CDC)

The CDC is also a key player in funding biometric data research in 2025, particularly in the context of public health initiatives. CDC funding supports the integration of biometric data for better disease surveillance, patient monitoring, and response to health emergencies.

These targeted governmental grants are shaping the future of biometric data research in 2025, making it central to advancements in clinical trials, healthcare, and data security. As biometric systems continue to evolve, the role of these funding sources will only grow in importance, supporting the ethical and efficient use of this technology across industries.

Private and Philanthropic Contributions in 2025

Private and philanthropic funding continues to complement federal investments, supporting the rapid adoption and application of biometric data in healthcare and clinical trials. In 2025, private sector funding is increasingly focused on integrating biometric data into decentralized clinical trials, patient monitoring, and real-time data collection systems.

Notable Private and Philanthropic Sources in 2025:

• Gates Foundation: The Gates Foundation continues to focus on global health challenges, including HIV, pneumonia, and vaccine development. The foundation’s funding in 2025 supports the use of biometric data in tracking patient outcomes, optimizing interventions, and improving healthcare delivery in resource-limited settings.
• Leducq Foundation: Focusing on cardiovascular research, the Leducq Foundation allocates funding in 2025 to projects that integrate biometric data and biostatistics to improve patient outcomes. Their funding supports both clinical trials and large-scale health data initiatives that use biometric data to monitor and manage chronic diseases.

Private and philanthropic funding often adapts quickly to new technologies, such as wearable devices, decentralized clinical trials, and digital biomarkers, accelerating the adoption of biometric data in innovative research models.

How Funding Trends Impact Hiring in Clinical Data Management and Biometrics

We’ve examined the funding trends influencing U.S. healthcare in 2025, with a strong emphasis on biometric technologies. However, these shifts also signal a growing demand for highly specialized talent. As investments intensify, particularly in Biometrics, organizations will require professionals who can effectively manage, analyze, and secure the increasing volume of biometric data generated in clinical trials and healthcare settings.

Let’s explore the key roles that will be essential to supporting these advancements.

Biostatisticians

With funding flowing into wearable devices, digital biomarkers, and personalized healthcare, biostatisticians will be crucial in managing the increased complexity of clinical trials. Their role will involve designing models that account for the influx of biometric data, ensuring it leads to actionable insights. 

As funding prioritizes innovations that drive national health improvements, these professionals will be essential in validating the data's integrity and drawing conclusions that influence treatment protocols.

Statistical Programmers

As AI-driven diagnostics and wearable health tech expand, statistical programmers will be needed to build systems that handle vast amounts of data. Funding directed at healthcare advancements, particularly for chronic disease management, will require them to automate data processing and ensure accuracy. 

These roles will be key in maintaining consistency across platforms, supporting the goal of accessible and actionable healthcare data.

Clinical Data Managers

Decentralized trials are on the rise, especially with funding aimed at enhancing patient monitoring. Clinical data managers will oversee the integration of biometric data from remote sources, ensuring it’s accurate and compliant with regulations. Their ability to manage complex data flows will be critical as trials become more personalized, supporting the push for improved national health outcomes.

Regulatory Affairs Specialists

As biometric data becomes more important in clinical trials, funding in 2025 will prioritize projects that handle vast amounts of patient data, particularly in areas like rare diseases and global health. 

A solid regulatory affairs team will be essential for securing funding. They ensure projects comply with regulations like HIPAA and safeguard patient data. Their work directly impacts a project’s ability to qualify for funding and succeed in clinical trials.

Closing Thoughts on Biometric Data Funding in Life Sciences

This year, the life sciences sector is seeing a surge in investments, particularly in areas like rare disease treatment and innovative research. With funding increasingly directed at developing new treatments and advancing healthcare technologies, the demand for skilled professionals to manage and interpret biometric data is growing rapidly.

From biostatisticians to regulatory affairs specialists, roles are expanding to support the handling of large, complex datasets. As the focus shifts to personalized medicine and real-time monitoring, data management and security expertise will be essential for driving breakthroughs in life sciences. The funding trend will undoubtedly create new opportunities and challenges for talent acquisition, shaping the industry's workforce for years to come.

Is Your Team Ready for the Future of Biometrics?

At Warman O’Brien, we bring specialist knowledge in Biometrics and CDM to address the growing demand for these pivotal roles. Trusted by leading pharma, CRO, and biotech organizations globally, we deliver the talent shaping the future of personalized medicine and treatments.

With a team of former industry experts, we are uniquely positioned to support your organization’s Biometrics recruitment needs—now and as opportunities evolve.

Contact us today to access exceptional professionals or explore the latest opportunities in Biometrics jobs.